Acquired Company

Omega Therapeutics was acquired in a Chapter 11 asset sale by Pioneering Medicines 08-B, Inc., an affiliate of Flagship Pioneering, with a Delaware court sale order approving the sale on 4/25/2025 and an effective date of 8/8/2025.

Show more

Biological Product (except Diagnostic) Manufacturing

Manufacturing

Start AI Chat

Market Cap

0.00

52 Wk Range

$N/A - $N/A

Previous Close

$0.14

Open

$0.14

Volume

N/A

Day Range

$0.14 - $0.14

Enterprise Value

0.00

Cash

30.38M

Avg Qtr Burn

-13.9M

Insider Ownership

1.67%

Institutional Own.

87.75%

Qtr Updated

09/30/24

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
OTX-2002 Details Cancer, Hepatocellular carcinoma, Liver cancer	Phase 2 Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.